What were Global Health Ltd's latest quarterly results?
Global Health Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -33.6%
- Revenue Growth YoY: +18.9%
- Operating Margin: 19.0%
Global Health Ltd (Hospitals) — fundamental analysis, earnings data, and key metrics. PE: 46.8. ROE: 16.5%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Global Health Ltd's latest quarterly results (Dec 2025) show
Global Health Ltd's current PE ratio is 46.8x.
Global Health Ltd's price-to-book ratio is 7.1x.
Global Health Ltd's fundamental strength based on key financial ratios
Global Health Ltd has a debt-to-equity ratio of N/A.
Global Health Ltd's return ratios over recent years
Global Health Ltd's operating cash flow is positive (FY2025).
Global Health Ltd's current dividend yield is 0.05%.
Global Health Ltd's shareholding pattern (Dec 2025)
Global Health Ltd's promoter holding has remained stable recently.
Global Health Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Global Health Ltd may be worth studying
Global Health Ltd investment thesis summary:
Global Health Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.